跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
KANPIDUO 16 MG/2,5 MG COMPRIMIDOS
Approved
STANDARD
KANPIDUO 16 MG/2,5 MG COMPRIMIDOS
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 14, 2024
Approval ID
bfec090d61821625
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
bfec090d61821625
Drug Cima Aemps Name
KANPIDUO 16 MG/2,5 MG COMPRIMIDOS
Register Number
89949
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Krka Farmaceutica S.L.
Authorization Date
2024-11-14
Dosage Form
COMPRIMIDO
Dose
16mg/2,5mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Krka D.D. Novo Mesto
Active Ingredients
INDAPAMIDA
2,5 mg
CANDESARTAN CILEXETILO
16 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 14, 2024
Approval ID
bfec090d61821625
Type
Standard
Back to CIMA-AEMPS Approvals
KANPIDUO 16 MG/2,5 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details